Jian Irish
Präsident bei METAGENOMI, INC.
Vermögen: 4 Mio $ am 31.05.2024
Aktive Positionen von Jian Irish
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
METAGENOMI, INC. | Direktor/Vorstandsmitglied | - | - |
Geschäftsführer | 01.01.2021 | - | |
Präsident | 01.11.2021 | - |
Karriereverlauf von Jian Irish
Ehemalige bekannte Positionen von Jian Irish
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Geschäftsführer | 01.01.2021 | 01.01.2022 |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Direktor/Vorstandsmitglied | 01.10.2018 | 01.04.2020 |
Technik-/Wissenschafts-/F&E-Leiter | 01.10.2018 | 01.04.2020 | |
SANOFI | Corporate Officer/Principal | 01.01.2014 | 01.01.2016 |
AMGEN INC. | Corporate Officer/Principal | - | - |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Geschäftsführer | 01.01.2021 | - |
Präsident | 01.11.2021 | - | |
KITE PHARMA INC | Corporate Officer/Principal | - | - |
Ausbildung von Jian Irish
Chiba University | Doctorate Degree |
East China University of Science & Technology | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
China | 3 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Operating Officer | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
AMGEN INC. | Health Technology |
SANOFI | Health Technology |
METAGENOMI, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Kite Pharma, Inc.
Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Jian Irish
- Erfahrung